Author:
Babiker Hani M.,Green Myke R.,Nelson Mark A.,Elquza Emad
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Surveillance, Epidemiology, and End Results Program. National Cancer Institute. SEER Stat Fact Sheets: Colon and Rectum Cancer, SEER 18 2004-2010. http://seer.cancer.gov/statfacts/html/colorect.html . Accessed Dec 29, 2014
2. Raymond E, Faivre S, Woynarowski JM et al (1998) Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 25(2 Suppl 5):4–12
3. Raymond E, Buquet-Fagot C, Djelloul S et al (1997) Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers. Anti-Cancer Drugs 8(9):876–85
4. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938–47
5. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–51
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献